Cargando…
Validation of the Alzheimer’s disease-resemblance atrophy index in classifying and predicting progression in Alzheimer’s disease
BACKGROUND: Automated tools for characterising dementia risk have the potential to aid in the diagnosis, prognosis, and treatment of Alzheimer’s disease (AD). Here, we examined a novel machine learning-based brain atrophy marker, the AD-resemblance atrophy index (AD-RAI), to assess its test-retest r...
Autores principales: | He, Qiling, Shi, Lin, Luo, Yishan, Wan, Chao, Malone, Ian B., Mok, Vincent C. T., Cole, James H., Anatürk, Melis |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9435378/ https://www.ncbi.nlm.nih.gov/pubmed/36062150 http://dx.doi.org/10.3389/fnagi.2022.932125 |
Ejemplares similares
-
Risk estimation before progression to mild cognitive impairment and Alzheimer’s disease: an AD resemblance atrophy index
por: Zhao, Lei, et al.
Publicado: (2019) -
MRI-based Alzheimer’s disease-resemblance atrophy index in the detection of preclinical and prodromal Alzheimer’s disease
por: Liu, Wanting, et al.
Publicado: (2021) -
Vascular and Alzheimer's disease markers independently predict brain atrophy rate in Alzheimer's Disease Neuroimaging Initiative controls
por: Barnes, Josephine, et al.
Publicado: (2013) -
Patterns of progressive atrophy vary with age in Alzheimer's disease patients
por: Fiford, Cassidy M., et al.
Publicado: (2018) -
Post-Ischemic Neurodegeneration of the Hippocampus Resembling Alzheimer’s Disease Proteinopathy
por: Pluta, Ryszard, et al.
Publicado: (2021)